ID28451A - Trisiklik piperidin-δ3 sebagai bahan farmasi - Google Patents

Trisiklik piperidin-δ3 sebagai bahan farmasi

Info

Publication number
ID28451A
ID28451A IDW20010779A ID20010779A ID28451A ID 28451 A ID28451 A ID 28451A ID W20010779 A IDW20010779 A ID W20010779A ID 20010779 A ID20010779 A ID 20010779A ID 28451 A ID28451 A ID 28451A
Authority
ID
Indonesia
Prior art keywords
triciclic
piperidin
pharmaceutical material
pharmaceutical
Prior art date
Application number
IDW20010779A
Other languages
English (en)
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Mirielle Braeken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ID28451A publication Critical patent/ID28451A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IDW20010779A 1998-10-06 1999-10-01 Trisiklik piperidin-δ3 sebagai bahan farmasi ID28451A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203371 1998-10-06

Publications (1)

Publication Number Publication Date
ID28451A true ID28451A (id) 2001-05-24

Family

ID=8234192

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010779A ID28451A (id) 1998-10-06 1999-10-01 Trisiklik piperidin-δ3 sebagai bahan farmasi

Country Status (27)

Country Link
US (1) US6352999B1 (id)
EP (1) EP1119570B1 (id)
JP (1) JP4590102B2 (id)
KR (1) KR20010071844A (id)
CN (1) CN1131868C (id)
AR (1) AR023679A1 (id)
AT (1) ATE269337T1 (id)
AU (1) AU759199B2 (id)
BG (1) BG64871B1 (id)
BR (1) BR9913108A (id)
CA (1) CA2346082C (id)
CZ (1) CZ20011105A3 (id)
DE (1) DE69918148T2 (id)
EE (1) EE04680B1 (id)
ES (1) ES2222735T3 (id)
HU (1) HUP0103749A3 (id)
ID (1) ID28451A (id)
IL (2) IL142444A0 (id)
NO (1) NO20011402L (id)
NZ (1) NZ510116A (id)
PL (1) PL347179A1 (id)
RU (1) RU2226194C2 (id)
SK (1) SK285386B6 (id)
TR (1) TR200100953T2 (id)
TW (1) TWI244485B (id)
UA (1) UA70961C2 (id)
WO (1) WO2000020423A1 (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
MXPA04000036A (es) * 2001-07-05 2004-05-21 Upjohn Co Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht.
US20050203100A1 (en) * 2002-04-03 2005-09-15 Jukka Sallinen Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
JP4816453B2 (ja) 2004-04-12 2011-11-16 大正製薬株式会社 環状アミン化合物
JP2008530229A (ja) 2005-02-17 2008-08-07 ワイス シクロアルキル縮合インドール、ベンゾチオフェン、ベンゾフランおよびインデン誘導体
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
WO2015012515A1 (ko) * 2013-07-25 2015-01-29 동아에스티 주식회사 벤즈아미드 유도체의 제조방법, 그의 제조에 사용되는 새로운 중간체 및 상기 중간체의 제조방법
CN103755715B (zh) * 2013-12-26 2015-12-09 武汉理工大学 苯并呋喃并[2,3-c]吡啶化合物及其合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU926914A1 (ru) * 1980-05-26 1992-04-23 Научно-исследовательский институт фармакологии АМН СССР Производные 1,2,3,4-тетрагидробензофуро[3,2-с]-пиридина или хлоргидрат, обладающие р дом свойств анальгетиков и антагонистов морфина
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
US4971974A (en) * 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
WO1998024791A1 (en) * 1996-12-06 1998-06-11 Abbott Laboratories Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ

Also Published As

Publication number Publication date
BR9913108A (pt) 2001-05-08
SK285386B6 (sk) 2006-12-07
EE200100210A (et) 2002-06-17
TR200100953T2 (tr) 2001-09-21
EP1119570A1 (en) 2001-08-01
EE04680B1 (et) 2006-08-15
NZ510116A (en) 2002-10-25
HUP0103749A2 (hu) 2002-02-28
IL142444A0 (en) 2002-03-10
BG105334A (bg) 2001-11-30
ATE269337T1 (de) 2004-07-15
AU6334299A (en) 2000-04-26
NO20011402D0 (no) 2001-03-20
HK1038009A1 (en) 2002-03-01
NO20011402L (no) 2001-03-20
EP1119570B1 (en) 2004-06-16
UA70961C2 (uk) 2004-11-15
KR20010071844A (ko) 2001-07-31
RU2226194C2 (ru) 2004-03-27
DE69918148D1 (de) 2004-07-22
DE69918148T2 (de) 2005-07-28
AU759199B2 (en) 2003-04-10
HUP0103749A3 (en) 2003-03-28
US6352999B1 (en) 2002-03-05
CA2346082C (en) 2010-02-16
CN1321158A (zh) 2001-11-07
JP2002526547A (ja) 2002-08-20
JP4590102B2 (ja) 2010-12-01
PL347179A1 (en) 2002-03-25
WO2000020423A1 (en) 2000-04-13
IL142444A (en) 2008-03-20
CN1131868C (zh) 2003-12-24
CZ20011105A3 (cs) 2001-12-12
CA2346082A1 (en) 2000-04-13
BG64871B1 (bg) 2006-07-31
ES2222735T3 (es) 2005-02-01
SK4332001A3 (en) 2001-12-03
TWI244485B (en) 2005-12-01
AR023679A1 (es) 2002-09-04

Similar Documents

Publication Publication Date Title
ID27415A (id) Komposisi farmaseutik
NO20005913D0 (no) Legemiddelsammensetning
NO20005218L (no) Farmasöytisk aerosolpreparat
DK0920302T4 (da) Farmaceutisk aerosolsammensætning
DE69827987D1 (de) Verpackungsmaterial
DE60011720D1 (de) Verbindungsmaterial
ID29262A (id) Komposisi farmasi
DK1466615T3 (da) Farmaceutisk præparat
NO992692D0 (no) Nefadozon doseringsform
DE69922710D1 (de) Gasadsorbierendes material
ID27201A (id) Komposisi farmasi
ID27996A (id) Polimorf dari suatu bahan farmasi
ID27150A (id) Sediaan levotiroksin bahan farmasi
EE9900545A (et) Farmatseutiline kompositsioon
FI972210A0 (fi) Icke-svettdrivande material
FI974634A0 (fi) Anordning foer matning av material
ID29294A (id) Komposisi farmasi
DE69803996D1 (de) Verpackungsmaterial
ID25857A (id) Komposisi farmasi
NO991727D0 (no) Materialutlegger
ID26215A (id) Komposisi farmasi
EE200000401A (et) Farmatseutilise preparaadi valmistamismeetod
DE69912386D1 (de) Abschleifbares Material
NO20013232L (no) Faststoffmateriale
ID23531A (id) Komposisi farmasi